Product Images Divalproex Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Divalproex Sodium NDC 67046-147 by Contract Pharmacy Services-pa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structure - b937b05a c544 4ba2 9047 4b3e85f6c164 01

Structure - b937b05a c544 4ba2 9047 4b3e85f6c164 01

Comparison of percentage of patient separated by study - b937b05a c544 4ba2 9047 4b3e85f6c164 02

Comparison of percentage of patient separated by study - b937b05a c544 4ba2 9047 4b3e85f6c164 02

This text is indicating some data points related to Study 1 and Study 2, which are possibly related to YMRS and MRS. However, there is not enough information to determine the specific context or purpose of these data points.*

% Reduction in CPS Rate Vs % of Patients - b937b05a c544 4ba2 9047 4b3e85f6c164 03

% Reduction in CPS Rate Vs % of Patients - b937b05a c544 4ba2 9047 4b3e85f6c164 03

This document appears to be a table summarizing the % reduction in CPS (clinical global impression-severity) rate for patients taking Divalproex Sodium versus a placebo. The table shows a 25% reduction rate for those taking Divalproex Sodium and a -100% reduction rate for those taking placebo, meaning the CPS rate worsened for those taking a placebo. The table also includes the % of patients who experienced improvement or worsening in their CPS rate.*

% reduction in CPS Rate Vs % of Patients - b937b05a c544 4ba2 9047 4b3e85f6c164 04

% reduction in CPS Rate Vs % of Patients - b937b05a c544 4ba2 9047 4b3e85f6c164 04

Mean 4-week Migraine Rates - b937b05a c544 4ba2 9047 4b3e85f6c164 05

Mean 4-week Migraine Rates - b937b05a c544 4ba2 9047 4b3e85f6c164 05

This text appears to be describing a study involving a medication called Divalproex Sodium. There are also mentions of a placebo group in both Study 1 and Study 2. However, without more information on the specifics of the study and its results, it is difficult to provide a more detailed description.*

Company Logo - b937b05a c544 4ba2 9047 4b3e85f6c164 06

Company Logo - b937b05a c544 4ba2 9047 4b3e85f6c164 06

This is a very short text that simply mentions the name of a company - UNICHEM PHARMACEUTICALS (USA). INC. No further information is provided.*

Container Label 250 mg - b937b05a c544 4ba2 9047 4b3e85f6c164 08

Container Label 250 mg - b937b05a c544 4ba2 9047 4b3e85f6c164 08

This is a prescription drug called Divalproex Sodium which comes in the form of 250mg tablets. The package contains 30 tablets and the enclosure provides information on how to take the medication. The drug has an expiration date of 05/04/18 and it should be stored at 20-25°C (68-77°F). The drug is manufactured by Unichem and package by Contract Pharmacy Services-PA. The pill ID is UL250.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.